Anticonvulsant effects of eliprodil alone or combined with the glycine(B) receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats

Neuropharmacology

Volumn 38, Issue 2, 1999, Pages 243-251

  Wlaź, Piotr ^a,b   Ebert, Ulrich ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Amygdala; Epilepsy; Excitatory amino acids; Glutamate; Ifenprodil

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; ANTICONVULSIVE AGENT; ELIPRODIL; GLUTAMIC ACID; GLYCINE; GLYCINE RECEPTOR ANTAGONIST; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POLYAMINE; RECEPTOR SUBUNIT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

2-AMINO-5-PHOSPHONOVALERATE; AMYGDALA; ANIMALS; ANTICONVULSANTS; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; KINDLING, NEUROLOGIC; PIPERIDINES; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032970078     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00184-1     Document Type: Article

References (47)

1. Avenet, P., Léonardon, J., Besnard, F., et al., 1996. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Eur. J. Pharmacol. 296, 209-213.
2. Avenet, P., Léonardon, J., Besnard, F., Graham, D., Depoortere, H., Scatton, B., 1997. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci. Lett. 223, 133-136.
3. 2+ channels and in gerbil global cerebral ischaemia. Eur. J. Pharmacol. 299, 103-112.
4. 2+ channels in rat cultured cortical neurons. Eur. J. Pharmacol. 257, 297-301.
5. 2+ channels by the NMDA receptor antagonist eliprodil in acutely dissociated rat Purkinje cells. Eur. J. Pharmacol. 294, 91-100.
6. 3H-D-aspartate release. Biochem. Pharmacol. 35, 2949-2953.
7. Bristow, L.J., Hutson, P.H., Kulagowski, J.J., et al., 1996. The anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. J. Pharmacol. Exp. Therapeutics 279, 492-501.
8. 3H]TCP binding. Br. J. Pharmacol. 105 (Suppl.), 18 p.
9. Chapman, A.G., Graham, J.L., Patel, S., Meldrum, B.S., 1991. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Epilepsia 32, 578-587.
10. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions. Br. J. Pharmacol. 113, 499-507.
11. Cotterell, K.L., Croucher, M.J., Bradford, H.F., 1992. Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration. Eur. J. Pharmacol. 214, 285-287.
12. Croucher, M.J., Collins, J.F., Meldrum, B.S., 1982. Anticonvulsant action of excitatory amino acid antagonists. Science 216, 899-901.
13. Czechowska, G., Dziki, M., Pietrasiewicz, T., Kleinrok, Z., Turski, W.A., Czuczwar, S.J., 1993. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice. Eur. J. Pharmacol. 232, 59-64.
14. Czuczwar, S.J., Meldrum, B., 1982. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur. J. Pharmacol. 83, 335-338.
15. Dereń-Wesoełk, A., Maj, J., 1993. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex. Polish J. Pharmacol. 45, 467-480.
16. Dürmüller, N., Craggs, M., Meldrum, B.S., 1994. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res. 17, 167-174.
17. Ebert, U., Rundfeldt, C., Löscher, W., 1995. Development and pharmacological suppression of secondary after-discharges in the hippocampus of amygdala-kindled rats. Eur. J. Neurosci. 7, 732-741.
18. Ebert, U., Wlaź, P., Löscher, W., 1997. Anticonvulsant effects by combined treatment with a glycineB receptor antagonist and a polyamine site antagonist in amygdala-kindled rats. Eur. J. Pharmacol. 322, 179-184.
19. Gotti, B., Duverger, D., Bertin, J., et al., 1988. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmacol. Exp. Therapeutics 247, 1211-1221.
20. Johnson, J.W., Ascher, P., 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531.
21. Juul-Jensen, P., 1986. Epidemiology of intractable epilepsy. In: Schmidt, D., Morselli, P. (Eds.), Intractable Epilepsy: Experimental and Clinical Aspects. Raven Press, New York, pp. 5-11.
22. Kotlińska, J., Liljequist, S., 1996. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures. Psychopharmacology 127, 238-244.
23. Kutsuwada, T., Kashiwabuchi, N., Mori, H., et al., 1992. Molecular diversity of the NMDA receptor channel. Nature 358, 36-41.
24. Legendre, P., Westbrook, G.L., 1991. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol. Pharmacol. 40, 289-298.
25. Lippert, K., Welsch, M., Krieglstein, J., 1994. Over-additive protective effect of dizocilpine and NBQX against neuronal damage. Eur. J. Pharmacol. 253, 207-213.
26. Löscher, W., Nolting, B., Hönack, D., 1988. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital. Eur. J. Pharmacol. 152, 9-17.
27. Löscher, W., 1993. Basic aspects of epilepsy. Curr. Opin. Neurol. Neurosurg. 6, 223-232.
28. Löscher, W., Rundfeldt, C., Hönack, D., 1993. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur. J. Neurosci. 5, 1545-1550.
29. Löscher, W., Hönack, D., 1991a. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Therapeutics 256, 432-440.
30. 1A receptors. J. Pharmacol. Exp. Therapeutics 257, 1146-1153.
31. Löscher, W., Hönack, D., 1991c. Responses to NMDA receptor antagonists altered by epileptogenesis. Trends Pharmacol. Sci. 12, 52.
32. Löscher, W., Schmidt, D., 1988. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2, 145-181.
33. McCool, B.A., Lovinger, D.M., 1995. Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor. Neuropharmacology 34, 621-629.
34. McNamara, J.O., Russell, R.D., Rigsbee, L., Bonhaus, D.W., 1988. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 27, 563-568.
35. Meldrum, B.S., Croucher, M.J., Badman, G., Collins, J.F., 1983. Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio. Neurosci. Lett. 39, 101-104.
36. Mori, H., Mishina, M., 1995. Structure and function of the NMDA receptor channel. Neuropharmacology 34, 1219-1237.
37. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
38. Pullan, L.M., Stumpo, R.J., Powel, R.J., Paschetto, K.A., Britt, M., 1992. Neomycin is an agonist at a polyamine site on the N-methyl-D-aspartate receptor. J. Neurochem. 59, 2087-2093.
39. Racine, R.J., 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294.
40. Schmutz, M., Portet, C., Jeker, A., et al., 1990. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn-Schmiedebergs Arch. Pharmacol. 342, 61-66.
41. Sveinbjornsdottir, S., Sander, J.W., Upton, D., et al., 1993. The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res. 16, 165-174.
42. Toulmond, S., Serrano, A., Benavides, J., Scatton, B., 1993. Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window. Brain Res. 620, 32-41.
43. Voltz, C., Fage, D., Carter, C., 1994. Synergism between the NMDA receptor antagonistic effects of ifenprodil and the glycine antagonist, 7-chlorokynurenate, in vivo. Eur. J. Pharmacol. 255, 197-202.
44. Williams, K., 1993. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851-859.
45. Williams, K., Romano, C., Dichter, M.A., Molinoff, P.B., 1991. Modulation of the NMDA receptor by polyamines. Life Sci. 48, 469-498.
46. Wlaź, P., Baran, H., Löscher, W., 1994. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice. Eur. J. Pharmacol. 257, 217-225.
47. B receptor antagonists in the amygdala kindling model in rats. Eur. J. Pharmacol. 342, 39-46.